Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAO study of exenatide for antipsychotic-associated obesity
2012-005404-17Phase 4Completed
- Sponsor
- Center for Neuropsychiatric Schizophrenia Research
- Start
- Jan 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in obesity, sponsored by Center for Neuropsychiatric Schizophrenia Research. Started Jan 2013; status: completed.
02
Drugs
exenatide
03
Conditions
obesity
Beyond the preview
Go deeper on 2012-005404-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005404-17.